ResMed (RMD) Valuation Check After New Greenwood Distribution Expansion Announcement

Simply Wall St.03-03

ResMed (RMD) is expanding its U.S. footprint with a new distribution center in Greenwood, Indiana, planned to begin operations in 2027. The facility aims to widen North American coverage for its sleep...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2616364700?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-03-03 06:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616364700","market":"sg","top_or_hot":-1,"title":"ResMed (RMD) Valuation Check After New Greenwood Distribution Expansion Announcement","media":"Simply Wall St.","content":"<div>\n<p>ResMed (RMD) is expanding its U.S. footprint with a new distribution center in Greenwood, Indiana, planned to begin operations in 2027. The facility aims to widen North American coverage for its sleep...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/resmed-rmd-valuation-check-after-new-greenwood-distribution\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ResMed (RMD) Valuation Check After New Greenwood Distribution Expansion Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nResMed (RMD) Valuation Check After New Greenwood Distribution Expansion Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-03 06:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/resmed-rmd-valuation-check-after-new-greenwood-distribution><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ResMed (RMD) is expanding its U.S. footprint with a new distribution center in Greenwood, Indiana, planned to begin operations in 2027. The facility aims to widen North American coverage for its sleep...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/resmed-rmd-valuation-check-after-new-greenwood-distribution\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RMD.AU","symbol_name":"Resmed DRC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/resmed-rmd-valuation-check-after-new-greenwood-distribution","article_id":"2616364700","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-rmd/resmed/news/resmed-rmd-valuation-check-after-new-greenwood-distribution","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2616364700","pubTimestamp":1772489714,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"ResMed (RMD) is expanding its U.S. footprint with a new distribution center in Greenwood, Indiana, planned to begin operations in 2027. The facility aims to widen North American coverage for its sleep and respiratory care products.\nSee our latest analysis for ResMed.\nResMed’s new Greenwood distribution hub comes as the stock has eased slightly in the short term, with a 7 day share price return showing a 1.74% decline, while longer term performance looks steadier, including a 1 year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"RMD.AU":"Resmed DRC","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","BK7501":"新冠治疗股","BK4585":"ETF&股票定投概念","BK7007":"医疗保健设备","BK4588":"碎股","BK4567":"ESG概念","BK4548":"巴美列捷福持仓","BK4082":"医疗保健设备","BK4504":"桥水持仓","LU2008162690.USD":"FIDELITY FUNDS - ASIA PACIFIC OPPORTUNITIES \"A\" (USD) ACC","LU2177674079.SGD":"Fidelity Asia Pacific Opportunities A-ACC-SGD (hedged)","RMD":"瑞思迈","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC"},"translate_title":"新的Greenwood分销扩张公告后瑞思迈(RMD)估值检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMD":1,"RMD.AU":1.5},"content_text":"ResMed (RMD) is expanding its U.S. footprint with a new distribution center in Greenwood, Indiana, planned to begin operations in 2027. The facility aims to widen North American coverage for its sleep and respiratory care products. See our latest analysis for ResMed. ResMed’s new Greenwood distribution hub comes as the stock has eased slightly in the short term, with a 7 day share price return showing a 1.74% decline, while longer term performance looks steadier, including a 1 year total shareholder return of 10.92% and a 5 year total shareholder return of 49.08%. If this logistics expansion has you thinking about how healthcare and technology intersect, it could be a good time to check out 28 healthcare AI stocks as another way to source ideas in this space. With ResMed shares easing in the short term but showing stronger multi year total returns, along with an indicated discount to both analyst targets and intrinsic value estimates, is this a genuine buying opportunity, or is the market already pricing in future growth? AdvertisementMost Popular Narrative: 13.9% Undervalued ResMed's most followed narrative pegs fair value at $297.47, above the last close of $256.26, framing the stock as modestly undervalued on that view.  Optimization initiatives in procurement, manufacturing, and logistics, along with the build out of the U.S. manufacturing footprint, are structurally improving gross margins. When combined with operating leverage from global scale, these factors are expected to boost overall earnings and free cash flow.  Read the complete narrative. Curious what kind of revenue run rate, margin profile, and future earnings power this fair value leans on, and how tightly analysts cluster around those assumptions. Result: Fair Value of $297.47 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this fair value view could be challenged if reimbursement pressure hits device pricing or if alternative sleep apnea therapies start to cap demand for ResMed’s hardware. Find out about the key risks to this ResMed narrative. Next Steps If this mix of potential upside and risks leaves you on the fence, it makes sense to move quickly and test the numbers yourself, starting with 4 key rewards. Looking for more investment ideas? If ResMed is on your radar, do not stop here; broaden your watchlist with focused sets of stocks that match the kind of portfolio you want to build.  Target potential mispricings by scanning our list of 49 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect their underlying strength. Prioritize steadier profiles by reviewing 76 resilient stocks with low risk scores, highlighting companies that score well on factors linked to resilience and lower overall risk. Hunt for early opportunities with screener containing 24 high quality undiscovered gems, a collection of under the radar names that still show solid financial traits.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2616364700","isCrawlerRequest":true}